Tumour mutational burden and survival with molecularly matched therapy

de Bortoli, T; Benary, M; Horak, P; Lamping, M; Stintzing, S; Tinhofer, I; Leyvraz, S; Schäfer, R; Klauschen, F; Keller, U; Stenzinger, A; Fröhling, S; Kurzrock, R; Keilholz, U; Rieke, DT; Jelas, I

Rieke, DT; Jelas, I (通讯作者)，Charite Univ Med Berlin, Charite Comprehens Canc Ctr, Charitepl 1, D-10117 Berlin, Germany.;Rieke, DT (通讯作者)，Charite Univ Med Berlin, Dept Hematol Oncol & Canc Immunol, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany.;Jelas, I (通讯作者)，Charite Univ Med Berlin, Dept Hematol Oncol & Canc Immunol, Campus Charite Mitte,Charitepl 1, D-10117 Berlin, Germany.

EUROPEAN JOURNAL OF CANCER, 2023; 190 ():

Abstract

Background: The impact of tumour mutational burden (TMB) on outcome with molecularly matched therapy is unknown. Higher TMB could predict resistance t......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索